Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    April 2018
  1. MCLACHLAN SM, Rapoport B
    A Role for Satb1 in Thyroid Autoimmunity?
    Thyroid. 2018 Apr 5. doi: 10.1089/thy.2017.0713.
    PubMed     Text format    


    March 2018
  2. HAN YE, Hwang S, Kim JH, Byun JW, et al
    Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Thyroid. 2018 Mar 28. doi: 10.1089/thy.2017.0338.
    PubMed     Text format     Abstract available


    February 2018
  3. LATROFA F, Ricci D, Bottai S, Brozzi F, et al
    Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0052.
    PubMed     Text format     Abstract available


    January 2018
  4. YANG X, Lun Y, Jiang H, Liu X, et al
    SIRT1-regualted abnormal acetylation of FOXP3 induces Treg function defect in Hashimoto's thyroiditis.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0286.
    PubMed     Text format     Abstract available


  5. PAPADAKIS GE, Lamine F, Chtioui H, Moschouri E, et al
    Rapid remission of Graves' hyperthyroidism without thionamides under immunosuppressive treatment for concomitant autoimmune hepatitis.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0613.
    PubMed     Text format     Abstract available


  6. SABINI E, Mazzi B, Profilo MA, Mautone T, et al
    SERUM HIGH CHOLESTEROL IS A NOVEL RISK FACTOR FOR GRAVES' ORBITOPATHY (GO): RESULTS OF A CROSS-SECTIONAL STUDY.
    Thyroid. 2018 Jan 16. doi: 10.1089/thy.2017.0430.
    PubMed     Text format     Abstract available


  7. ZHAO F, Feng J, Li J, Zhao L, et al
    Alterations of the gut microbiota in Hashimoto's thyroiditis patients.
    Thyroid. 2018 Jan 10. doi: 10.1089/thy.2017.0395.
    PubMed     Text format     Abstract available


    November 2017
  8. WATANABE M, Takenaka Y, Honda C, Twin Research Group O, et al
    Genotype-based epigenetic differences in monozygotic twins discordant for positive anti-thyroglobulin autoantibodies.
    Thyroid. 2017 Nov 4. doi: 10.1089/thy.2017.0273.
    PubMed     Text format     Abstract available


    October 2017
  9. YANG J, Yao LP, Dong M, Xu Q, et al
    Clinical characteristics and outcomes of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in patients with Graves' disease: A median 38-month retrospective cohort study from a single institution in China.
    Thyroid. 2017 Oct 31. doi: 10.1089/thy.2017.0468.
    PubMed     Text format     Abstract available


  10. FERLOV-SCHWENSEN C, Brix TH, Hegedus L
    Death by suicide in Graves' disease and Graves' orbitopathy. A nationwide Danish register study.
    Thyroid. 2017 Oct 30. doi: 10.1089/thy.2017.0365.
    PubMed     Text format     Abstract available


  11. HASHIMOTO K, Nishihara E, Matsumoto M, Matsumoto S, et al
    Sialic acid-binding immunoglobulin-like lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease -A multicenter study.
    Thyroid. 2017 Oct 17. doi: 10.1089/thy.2017.0244.
    PubMed     Text format     Abstract available


    September 2017
  12. GERSHENGORN MC
    No direct evidence for IGF-1 receptor (IGF-1R) stimulating antibodies in Graves' orbitopathy.
    Thyroid. 2017.
    PubMed     Text format     Abstract available


    August 2017
  13. CHEN CW, Huang YL, Huang RL, Tzeng CR, et al
    Idiopathic low ovarian reserve is associated with more frequent positive thyroid peroxidase antibody.
    Thyroid. 2017 Aug 16. doi: 10.1089/thy.2017.0139.
    PubMed     Text format     Abstract available


  14. YU SH, Kang JG, Kim CS, Ihm SH, et al
    Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
    Thyroid. 2017 Aug 12. doi: 10.1089/thy.2017.0126.
    PubMed     Text format     Abstract available


    July 2017
  15. SWEGAL WC, Chang SS, Singer MC
    Referral Trends for Surgical Management of Graves' Disease.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0145.
    PubMed     Text format     Abstract available


  16. TORIMOTO K, Okada Y, Nakayamada S, Kubo S, et al
    Anti-PD-1 antibody therapy induces Hashimoto's disease with increase in peripheral blood follicular helper T cells.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0062.
    PubMed     Text format     Abstract available


  17. AL-MAJDOUB M, Lantz M, Spegel P
    Treatment of Swedish Patients with Graves' Hyperthyroidism is Associated with Changes in Acylcarnitine Levels.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0218.
    PubMed     Text format     Abstract available


    June 2017
  18. HAIDER U, Richards P, Gianoukakis A
    Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm.
    Thyroid. 2017 Jun 3. doi: 10.1089/thy.2017.0086.
    PubMed     Text format     Abstract available


    May 2017
  19. CHEN Y, Chen Y, Xia F, Wang N, et al
    A Higher Ratio of Estradiol to Testosterone is associated with Autoimmune Thyroid Disease in Males.
    Thyroid. 2017 May 30. doi: 10.1089/thy.2016.0661.
    PubMed     Text format     Abstract available


  20. GIESECKE P, Rosenqvist M, Frykman V, Friberg L, et al
    Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2017.0029.
    PubMed     Text format     Abstract available


    April 2017
  21. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Text format     Abstract available


  22. LIU T, Sun J, Wang Z, Yang W, et al
    Changes in the DNA methylation and hydroxymethylation status of the intercellular adhesion molecule 1 gene promoter in thyrocytes from autoimmune thyroiditis patients.
    Thyroid. 2017 Apr 7. doi: 10.1089/thy.2016.0576.
    PubMed     Text format     Abstract available


  23. KIM YA, Cho SW, Choi HS, Moon S, et al
    The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
    Thyroid. 2017;27:491-496.
    PubMed     Text format     Abstract available


    March 2017
  24. LI C, Peng S, Liu X, Han C, et al
    Glycyrrhizin, a direct HMGB1 antagonist, ameliorates inflammatory infiltration in a model of autoimmune thyroiditis via inhibition of TLR2-HMGB1 signaling.
    Thyroid. 2017 Mar 31. doi: 10.1089/thy.2016.0432.
    PubMed     Text format     Abstract available


  25. HU S, Rayman MP
    Multiple nutritional factors and the risk of Hashimoto's Thyroiditis.
    Thyroid. 2017 Mar 14. doi: 10.1089/thy.2016.0635.
    PubMed     Text format     Abstract available


    January 2017
  26. ZAGHLOL R, Haghighi A, Alkhayyat M, Farhan O, et al
    Consanguinity and the risk of Hashimoto's Thyroiditis.
    Thyroid. 2017 Jan 6. doi: 10.1089/thy.2016.0495.
    PubMed     Text format     Abstract available


  27. SUNDARESH V, Brito JP, Thapa P, Bahn RS, et al
    Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism - A Historical Cohort Study.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0343.
    PubMed     Text format     Abstract available


    November 2016
  28. ROTONDO DOTTORE G, Leo M, Casini G, Latrofa F, et al
    ANTI-OXIDANT ACTIONS OF SELENIUM IN ORBITAL FIBROBLASTS: A BASIS FOR THE EFFECTS OF SELENIUM IN GRAVES' ORBITOPATHY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    October 2016
  29. MALHOTRA S, Heptulla RA, Homel P, Motaghedi R, et al
    Effect of marijuana use on thyroid function and autoimmunity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  30. HATTORI N, Ishihara T, Matsuoka N, Saito T, et al
    Anti-TSH autoantibodies in patients with macro-TSH and long-term changes in macro-TSH and serum TSH levels.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  31. FUJII A, Inoue N, Watanabe M, Kawakami C, et al
    <i>TSHR</i>genepolymorphisms intheenhancerregions are most strongly associatedwiththe development of Graves' disease, especially intractable disease, and with that of Hashimoto's disease.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  32. WICHMAN J, Winther KH, Bonnema SJ, Hegedus L, et al
    Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    September 2016
  33. HIRATSUKA I, Yamada H, Munetsuna E, Hashimoto S, et al
    Circulating microRNAs in Graves' Disease in Relation to Clinical Activity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  34. WU T, Mester T, Gupta S, Sun F, et al
    TSH and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for pathogenesis of Thyroid Associated Ophthalmopathy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  35. AVERSA T, Corrias A, Salerno M, Tessaris D, et al
    Five-year prospective evaluation of thyroid function test evolution in children with Hashimoto's thyroiditis presenting with either euthyroidism or subclinical hypothyroidism.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  36. TETI C, Nazzari E, Galletti M, Mandolfino MG, et al
    Unexpected elevated free thyroid hormones in pregnancy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  37. CHNG CL, Lim AY, Tan HC, Kovalik JP, et al
    Physiological and metabolic changes during the transition from hyperthyroidism to euthyroidism in Graves' disease.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  38. CRAMON P, Winther KH, Watt T, Bonnema SJ, et al
    Quality of life impairments persist six months after treatment of Graves' hyperthyroidism and toxic nodular goiter: A prospective cohort study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    June 2016
  39. WERION A, Joris V, Hepp M, Papasokrati L, et al
    Pioglitazone, a PPARgamma agonist, upregulates the expression of caveolin-1 and catalase, essential for thyroid cell homeostasis. A clue to the pathogenesis of Hashimoto's thyroiditis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  40. SHARMA R, Di Dalmazi G, Caturegli P Dr
    Exacerbation of Autoimmune Thyroiditis by CTLA-4 blockade: a role for IFNgamma-induced indoleamine 2, 3-dioxygenase.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  41. BRITO JP, Schilz S, Singh Ospina NM, Rodriguez-Gutierrez R, et al
    Antithyroid Drugs- the most common treatment for Graves' disease in the United States: a nationwide population-based study.
    Thyroid. 2016.
    PubMed     Text format    


  42. PANI F, Atzori F, Baghino G, Boi F, et al
    HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  43. TUN NN, Beckett G, Zammitt N, Strachan MW, et al
    Thyrotropin receptor antibody levels at diagnosis and after thionamide course predict Graves' disease relapse.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  44. ROY A, Laszkowska M, Sundstrom J, Lebwohl B, et al
    Prevalence of celiac disease in patients with autoimmune thyroid disease - a meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    April 2016
  45. ZHYZHNEUSKAYA S, Addison C, Tsatlidis V, Weaver IU, et al
    The natural history of subclinical hyperthyroidism in Graves' disease - the rule of thirds.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  46. BARBESINO G
    Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    March 2016
  47. LATROFA F, Ricci D, Sisti E, Piaggi P, et al
    Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  48. STRUJA TM, Guebelin L, Kutz A, Fehlberg H, et al
    Does Immunosuppressive Therapy Improve Outcomes in Graves' disease? A Systematic Review and Meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    February 2016
  49. DONNELLY PE, Winch DE, Pollard J
    Thyroid Steal - Surgery for Graves' disease a Century ago.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  50. RUGGERI RM, Vicchio TM, Cristani M, Certo R, et al
    OXIDATIVE STRESS AND ADVANCED GLYCATION END PRODUCTS (AGEs) IN HASHIMOTO'S THYROIDITIS.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    January 2016
  51. LIU L, Wu L, Gao A, Zhang Q, et al
    The influence of dihydrotestosterone on the development of Graves' disease in female BALB/c mice.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    December 2015
  52. BJERGVED L, Carle A, Jorgensen T, Perrild H, et al
    Parity and 11-year serum thyrotropin and thyroid autoantibody change: A longitudinal population-based study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    August 2015
  53. PONTO KA, Binder H, Diana T, Matheis N, et al
    Prevalence, Phenotype, and Psychosocial Well-Being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy.
    Thyroid. 2015;25:942-8.
    PubMed     Text format     Abstract available


    July 2015
  54. KUMAR S, Coenen MJ, Iyer S, Bahn RS, et al
    The forkhead transcription factor Fox01 is regulated by both a stimulatory thyrotropin receptor antibody and insulin-like growth factor-1 in orbital fibroblasts from patients with Graves' ophthalmopathy.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    April 2015
  55. TOHMA Y, Akturk M, Altinova AE, Yassibas E, et al
    Circulating Levels of Orexin-A, Nesfatin-1, Agouti Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    March 2015
  56. YANG J, Li LF, Xu Q, Zhang J, et al
    Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Thyroid. 2015;25:278-83.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: